Smoking Behaviour and Mental Health Disorders—Mutual Influences and Implications for Therapy
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Tobacco use is strongly associated with a variety of psychiatric disorders. Smokers are more likely than non-smokers to meet current criteria for mental health conditions, such as mood disorders, anxiety disorders and psychosis. Evidence also suggest that smokers with psychiatric disorders may have more difficulty quitting, offering at least a partial explanation for why smoking rates are higher in this population. The mechanisms linking mental health conditions and cigarette smoking are complex and likely differ across each of the various disorders. The most commonly held view is that patients with mental health conditions smoke in an effort to regulate the symptoms associated with their disorder. However some recent evidence suggests that quitting smoking may actually improve mental health symptoms. This is particularly true if the tobacco cessation intervention is integrated into the context of ongoing mental health treatment. In this paper we reviewed and summarized the most relevant knowledge about the relationship between tobacco use and dependence and psychiatric disorders. We also reviewed the most effective smoking cessation strategies available for patients with psychiatric comorbidity and the impact of smoking behavior on psychiatric medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
BARKLEY, R. A., FISCHER, M., EDELBROCK, C. S., & SMALLISH, L. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199007000-00007 · Cited by 1,507
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1107 · Cited by 1,262 · cited 1×
“Cross-sectional studies report that over 30% of patients with current depression are daily smokers [95,96].”
BackgroundLinkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · cited 1×
“People with anxiety disorders may initiate and maintain smoking behavior in an attempt to self-regulate or cope with adverse emotional distress [74,75].”
BackgroundCauses of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087 · cited 1×
“People with schizophrenia have a shorter life expectancy than the general population, and chronic cigarette smoking has been suggested as a major contributing factor to higher morbidity and mortality from malignancy and cardiovascular and respiratory diseases in this group of patients, especially in people aged 35 to…”
BackgroundEffects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073 · cited 1×
“10%–24% for ADHD and non-ADHD, respectively) [45–48].”
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Effects of abstinence from tobacco: Valid symptoms and time course
Hughes, J. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701188919 · Cited by 801 · cited 1×
“During abstinence, withdrawal symptoms such as depressed mood, insomnia, and irritability [30] are hypothesized to occur because target nAChRs are either no longer occupied by nicotine or change from the desensitized to the active state and become responsive to nicotine, once more causing a strong urge to resume smoki…”
BackgroundTobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678 · cited 1×
“This electrophysiological abnormality has been linked to decreased hippocampus size in schizophrenics and a reduction in α7 nicotinic receptors on GABA-B inhibitory interneurons [40].”
BackgroundNicotine dependence, major depression, and anxiety in young adults
Breslau, N. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360033005 · Cited by 634 · cited 1×
“Conversely, smokers, as compared with nonsmokers, have significantly higher rates of lifetime depression [97].”
BackgroundReward deficiency syndrome: genetic aspects of behavioral disorders
Comings, D. E., & Blum, K. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26022-6 · Cited by 621
Benowitz, N. L., Porchet, H., Sheiner, L., & Jacob, P. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.107 · Cited by 619
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558
Grant, B. F., Stinson, F. S., Hasin, D. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Huang, B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1001 · Cited by 479
Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort
Boden, J. M., Fergusson, D. M., & Horwood, L. J. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.065912 · Cited by 477 · cited 1×
“Research on these mechanisms is sparse in BD, but several decades of research on the relationship between depression and smoking suggest causal pathways in both directions [85,86] and that these relationships”
BackgroundMolecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 1×
“Both ADHD and smoking are highly heritable; genetic factors account for 60%–80% and 56% of the two phenotypes respectively [50,51].”
BackgroundNortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
Hall, S. M., Reus, V. I., Muñoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., Frederick, S., & Triffleman, E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.683 · Cited by 385 · cited 1×
“the negative affect related to quitting [102].”
Kollins, S. H., McClernon, F. J., & Fuemmeler, B. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1142 · Cited by 369 · cited 1×
“In a population-based sample of over 15,000 young adults, a linear relationship was identified between the number of retrospectively self-reported ADHD symptoms and the lifetime risk of regular smoking [49] .”
BackgroundMcClave, A. K., McKnight-Eily, L. R., Davis, S. P., & Dube, S. R. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.188136 · Cited by 339 · cited 1×
“Cross-sectional studies have uniformly indicated that smoking, compared with not smoking, is associated with more panic relevant symptoms and impairment among both clinical [63,64] and”
BackgroundNeurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · cited 2×
“Indeed, nicotine-replacement therapy (NRT), such as nicotine gum and patch, is believed to act primarily at high-affinity α4β2 nAChRs [27], and”
BackgroundPredicting smoking cessation and major depression in nicotine-dependent smokers
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.7.1122 · Cited by 293
Incidence of Cancer Among Persons With Schizophrenia and Their Relatives
Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., & Lönnqvist, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.573 · Cited by 292 · cited 1×
“Candidate gene studies have identified a number of similar genetic markers associated with both ADHD and smoking phenotypes, suggesting that several common neurobiological mechanisms may give rise to this comorbidity [52–55].”
BackgroundFryer, J. D., & Lukas, R. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37928-5 · Cited by 283 · cited 1×
“The only FDA-approved non-nicotine medication for nicotine dependence is bupropion, believed to be effective because of its dopaminergic activity on the pleasure and reward pathways in the mesolimbic system and NAcc and because it acts as a noncompetitive nicotinic receptor antagonist [31,101].”
BackgroundDresel, S., Krause, J., Krause, K.-H., LaFougere, C., Brinkbäumer, K., Kung, H. F., Hahn, K., & Tatsch, K. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000330 · Cited by 278
Dwoskin, L. P., Rauhut, A. S., King‐Pospisil, K. A., & Bardo, M. T. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00178.x · Cited by 259 · cited 1×
“Bupropion has shown efficacy in treating adults with ADHD and has also been approved by the Food and Drug Administration as an aid to smoking cessation [147–149].”
BackgroundNicotine addiction: the possible role of functional upregulation
Buisson, B., & Bertrand, D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01979-9 · Cited by 254 · cited 1×
“the central nervous system (CNS) [25] and are considered the major subtype involved in regulating the addiction-relevant actions of nicotine [26].”
BackgroundHistory of depression and smoking cessation outcome: A meta-analysis.
Hitsman, B., Borrelli, B., McChargue, D. E., Spring, B., & Niaura, R. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.657 · Cited by 253 · cited 1×
“The lifetime prevalence of major depression is high among smokers in clinic based smoking treatment, with rates as high as 64% [99].”
BackgroundSmoking in Patients Receiving Psychotropic Medications: A Pharmacokinetic Perspective
Desai, H. D., Seabolt, J., & Jann, M. W. (2001) · CNS Drugs · doi:10.2165/00023210-200115060-00005 · Cited by 253
Smoking cessation in severe mental illness: what works?
Banham, L., & Gilbody, S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02946.x · Cited by 243
Varenicline improves mood and cognition during smoking abstinence
Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., Frey, J. M., Siegel, S., & Lerman, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.028 · Cited by 222 · cited 1×
“Furthermore, in a small, open-label study involving 14 smokers with schizophrenia, varenicline demonstrated a beneficial effect on the cognitive dimensions of nicotine withdrawal [140], similar to effects observed in healthy smokers [141].”
Backgroundal’Absi, M., Hatsukami, D., Davis, G. L., & Wittmers, L. E. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.10.014 · Cited by 193
Wilens, T. E., Haight, B. R., Horrigan, J. P., Hudziak, J. J., Rosenthal, N. E., Connor, D. F., Hampton, K. D., Richard, N. E., & Modell, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.027 · Cited by 193
Diaz, F. J., James, D., Botts, S., Maw, L., Susce, M. T., & De Leon, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00664.x · Cited by 179 · cited 1×
“Despite this variability in prevalence estimates, controlled population-based [62,79,81] and clinical studies [82–84] conducted in the U.”
McKenzie, M., Olsson, C. A., Jorm, A. F., Romaniuk, H., & Patton, G. C. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03002.x · Cited by 161
Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159 · cited 1×
“the tobacco habit [119].”
Cigarette smoking and mortality risk in people with schizophrenia
Kelly, D. L., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Boggs, D. L., Warren, K. R., Feldman, S., Shim, J.-C., Love, R. C., et al. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp152 · Cited by 158
Cigarette Smoking and Panic Psychopathology
Zvolensky, M. J., & Bernstein, A. (2005) · Current Directions in Psychological Science · doi:10.1111/j.0963-7214.2005.00386.x · Cited by 150 · cited 4×
“Rasmusson [68] has hypothesized that cortisol elevations induced by various factors (e.g., stress, conditioned contextual cues) enhance both tolerance and sensitization to various effects of nicotine, and may help account for increased smoking in those with PTSD and other anxiety disorders.”
BackgroundInfluentialThe Neuroendocrinology of Posttraumatic Stress Disorder: New Directions
Rasmusson, A. M., Vythilingam, M., & Morgan, C. A. (2003) · CNS Spectrums · doi:10.1017/s1092852900008841 · Cited by 144
Berrendero, F., Robledo, P., Trigo, J. M., Martín-García, E., & Maldonado, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.006 · Cited by 140
Wilens, T. E., Verlinden, M. H., Adler, L. A., Wozniak, P. J., & West, S. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.029 · Cited by 123
The effects of smoking on acth and cortisol secretion
Seyler, L. E., Fertig, J., Pomerleau, O., Hunt, D., & Parker, K. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90330-8 · Cited by 105
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania
Berk, M., Ng, F., Wang, W. V., Tohen, M., Lubman, D. I., Vieta, E., & Dodd, S. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.018 · Cited by 72
Biological basis for the co-morbidity between smoking and mood disorders
Mineur, Y. S., & Picciotto, M. R. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260902869964 · Cited by 51
McEachin, R. C., Saccone, N. L., Saccone, S. F., Kleyman-Smith, Y. D., Kar, T., Kare, R. K., Ade, A. S., Sartor, M. A., Cavalcoli, J. D., & McInnis, M. G. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-14 · Cited by 31 · cited 2×
“For example, data from the 1992–1993 National Comorbidity Survey (NCS) suggested that the prevalence of smoking in BD was 69% [62], whereas the more recent 2007 National Health Interview Survey (NHIS) showed a prevalence rate of 46% [79].”
Background
Cited by
Valeriani, G., Corazza, O., Bersani, F. S., Melcore, C., Metastasio, A., Bersani, G., & Schifano, F. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2431 · Cited by 41
Self-citationKlein, P., Lawn, S., Tsourtos, G., & van Agteren, J. (2019) · JMIR Human Factors · doi:10.2196/14023 · Cited by 35
“This is evident as people with mental illness often identify as smokers [6] and use smoking as a form of self-medication to help them cope with and relieve their symptoms of mental illness [4,6,7].”
Cessation Among State Quitline Participants with a Mental Health Condition
Kerkvliet, J. L., Wey, H., & Fahrenwald, N. L. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu239 · Cited by 29
Metadata
- Authors
- Minichino, A., Bersani, F., Calò, W., Spagnoli, F., Francesconi, M., Vicinanza, R., Delle Chiaie, R., & Biondi, M.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2013-10-10
- Volume
- 10
- Issue
- 10
- Pages
- 4790-4811
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W2049851073
- Cited by
- 104
- References
- 49
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.